ME Therapeutics Holdings Inc.
METX
CNSX
11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 236.63% | 131.98% | 160.52% | -- | 391.61% |
Total Receivables | -16.67% | 132.08% | 113.33% | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 40.98% | 46.09% | 66.67% | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 195.82% | 129.77% | 159.77% | -- | -- |
|
|||||
Total Current Assets | 195.82% | 129.77% | 159.77% | -- | -- |
Net Property, Plant & Equipment | 79,700.00% | 0.00% | -50.00% | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 220.99% | 129.74% | 159.68% | -- | -- |
|
|||||
Total Accounts Payable | 135.90% | -56.60% | -81.64% | -- | -- |
Total Accrued Expenses | 2,190.00% | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 29.15% | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | 853.85% | 3.85% | -- | -- |
Total Other Current Liabilities | -- | 853.85% | 3.85% | -- | -- |
Total Current Liabilities | 116.58% | -57.52% | -60.62% | -- | -- |
|
|||||
Total Current Liabilities | 116.58% | -57.52% | -60.62% | -- | -- |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 187.39% | -57.52% | -60.62% | -- | -- |
|
|||||
Common Stock & APIC | 30.89% | 35.52% | 38.07% | -- | -- |
Retained Earnings | -12.88% | -18.25% | -90.73% | -- | -- |
Treasury Stock & Other | 13.70% | 20.72% | 811.55% | -- | -- |
Total Common Equity | 227.72% | 182.88% | 209.57% | -- | 397.63% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 227.72% | 182.88% | 209.57% | -- | 397.63% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 227.72% | 182.88% | 209.57% | -- | 397.63% |
|